Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000472960 | SCV000558525 | benign | Fanconi anemia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000502408 | SCV000594690 | benign | not specified | 2021-11-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000502408 | SCV000603578 | benign | not specified | 2017-04-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001149874 | SCV001310873 | likely benign | Fanconi anemia complementation group D2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV001731702 | SCV001982336 | likely benign | not provided | 2020-12-11 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225628 | SCV002505224 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001149874 | SCV002813750 | likely benign | Fanconi anemia complementation group D2 | 2022-05-18 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001149874 | SCV004017651 | benign | Fanconi anemia complementation group D2 | 2023-07-07 | criteria provided, single submitter | clinical testing |